Clinical Trial

The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression

Name: The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression — clinical trial record (NCT06827431)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Record status

This record was last updated February 14, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.

Summary

The purpose of this study is to evaluate the efficacy and safety of Ammoxetine hydrochloride enteric-coated tablets in subjects with depression.

Trial Details

NCT Number	NCT06827431
Lead Sponsor	CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Conditions	Major Depressive Disorder (MDD)
Enrollment	770 participants
Start Date	2025-02-14
Primary Completion	2026-06-30 (estimated)
Study Completion	2026-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-02-14